(Q37405399)

20 August 2017

1 reference

title

Cutaneous squamous cell carcinoma. (English)

1 reference

20 August 2017

Jorge Garcia-Zuazaga

1

1 reference

PubMed ID

19256304

20 August 2017

Suzanne M Olbricht

series ordinal

2

1 reference

20 August 2017

1 January 2008

1 reference

20 August 2017

Advances in dermatology

1 reference

20 August 2017

24

1 reference

20 August 2017

33-57

1 reference

Clinicopathologic variants of cutaneous squamous cell carcinoma

20 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Nonmelanoma cancers of the skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Trends of nonmelanoma skin cancer from 1960 through 2000 in a Canadian population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Metastases from squamous cell carcinoma of the skin and lip. An analysis of twenty-seven cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

The Nordic profile of skin cancer incidence. A comparative epidemiological study of the three main types of skin cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Incidence of non-melanocytic skin cancer treated in Australia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Cryotherapy for skin cancer: results over a 5-year period using liquid nitrogen spray cryosurgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Non-melanoma skin cancer among Caucasians in four areas of the United States.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Incidence of nonmelanoma skin cancer in New Hampshire and Vermont

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Time trends and familial risks in squamous cell carcinoma of the skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Polymorphisms in DNA double-strand break repair genes and skin cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Markers of cutaneous human papillomavirus infection in individuals with tumor-free skin, actinic keratoses, and squamous cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification--part two

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Human papillomavirus-associated digital squamous cell carcinoma: literature review and report of 21 new cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

A prospective pilot study of antibodies against human papillomaviruses and cutaneous squamous cell carcinoma nested in the Oxford component of the European Prospective Investigation into Cancer and Nutrition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Biology of cutaneous squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

A population-based study of skin cancer incidence and prevalence in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Guidelines for the management of squamous cell carcinoma in organ transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Incidence of skin cancer after renal transplantation in The Netherlands.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Skin cancer in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Depletion of CD4+ cells exacerbates the cutaneous response to acute and chronic UVB exposure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Chemotherapy in the management of advanced cutaneous squamous cell carcinoma in organ transplant recipients: theoretical and practical considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Maintenance versus reduction of immunosuppression in renal transplant recipients with aggressive squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Reduction of immunosuppression for transplant-associated skin cancer: rationale and evidence of efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: a 16-year retrospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Immunosuppression in patients with metastatic squamous cell carcinoma from the skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Cancer, warts, and sunshine in renal transplant patients. A case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Acitretin for chemoprevention of non-melanoma skin cancers in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Cancer incidence before and after kidney transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Association of methylenetetrahydrofolate reductase polymorphism and the risk of squamous cell carcinoma in renal transplant patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Histologic subtyping and malignancy assessment of cutaneous squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Overexpression of phosphorylated-STAT3 correlated with the invasion and metastasis of cutaneous squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

An immunohistochemical study of E-cadherin expression in human squamous cell carcinoma of the skin: relationship between decreased expression of E-cadherin in the primary lesion and regional lymph node metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Ets-1 immunohistochemical expression in non-melanoma skin carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Metalloelastase (MMP-12) expression by tumour cells in squamous cell carcinoma of the vulva correlates with invasiveness, while that by macrophages predicts better outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

CD44-9v and CD44-10v are potential molecular markers for squamous cell carcinoma of the vulva

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

7 January 2021

Mechanisms of metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Metastatic cutaneous squamous cell carcinoma: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Regional lymph node metastasis from cutaneous squamous cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Mortality risk from squamous cell skin cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Prognosis in lower lip squamous cell carcinoma: assessment of tumor factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Desmoplastic squamous cell carcinoma of skin and vermilion surface: a highly malignant subtype of skin cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Prognostic and therapeutic use of microstaging of cutaneous squamous cell carcinoma of the trunk and extremities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Sentinel lymph node biopsy in cutaneous squamous cell carcinoma: a systematic review of the English literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in situ (Bowen's disease): A randomized, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Imiquimod 5% cream in the treatment of Bowen's disease and invasive squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Treatment of Bowen's disease with topical 5% imiquimod cream: retrospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

7 January 2021

Nonmelanoma skin cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Bowen's disease and 5-fluorouracil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Squamous cell carcinoma in situ (Bowen's disease) in renal transplant patients treated with 5% imiquimod and 5% 5-fluorouracil therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

THE TREATMENT OF SKIN CANCER. A STATISTICAL STUDY OF 1,341 SKIN TUMORS COMPARING RESULTS OBTAINED WITH IRRADIATION, SURGERY, AND CURETTAGE FOLLOWED BY ELECTRODESICCATION.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

The incidence of major complications from Mohs micrographic surgery performed in office-based and hospital-based settings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

A prospective evaluation of the incidence of complications associated with Mohs micrographic surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Squamous cell carcinoma of the lip treated with Mohs micrographic surgery: outcome at 5 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Squamous cell carcinoma of skin with perineural invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Curettage and electrodesiccation in the treatment of skin cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Electrocoagulation for skin cancer: An old oncologic tool revisited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Cryosurgery of cutaneous carcinomas. An 18-year study of 3,022 patients with 4,228 carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Radiation therapy of carcinomas of the skin of nose and nasal vestibule: a report of 1676 cases by the Groupe Europeen de Curiethérapie

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Carcinoma of the lip and selected sites of head and neck skin. A clinical study of 896 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

External irradiation of epithelial skin cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Results of radiotherapy for epithelial skin cancer of the pinna: the Princess Margaret Hospital experience, 1982-1993.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Radiotherapy for epithelial skin cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Squamous cell cancer: a practical approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Oral capecitabine plus subcutaneous interferon alpha in advanced squamous cell carcinoma of the skin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Role of capecitabine (Xeloda®) in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Capecitabine and irinotecan as first-line chemotherapy in patients with metastatic colorectal cancer: results of an extended phase I study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

Guidelines of care for Mohs micrographic surgery. American Academy of Dermatology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.007

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YADR.2008.09.007

1 reference

20 August 2017

1 reference

PubMed ID

19256304